| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutathione binding | 1.03e-05 | 18 | 157 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 1.62e-05 | 20 | 157 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.07e-05 | 49 | 157 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 5.11e-05 | 122 | 157 | 7 | GO:0072341 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 5.50e-05 | 10 | 157 | 3 | GO:0043225 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 7.49e-05 | 29 | 157 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | RAD51 VWA8 ATP13A1 ABCC5 ABCC11 MCM6 SMC2 ABCC6 NAV1 DDX23 MACF1 ABCC12 | 1.97e-04 | 441 | 157 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.02e-04 | 15 | 157 | 3 | GO:0008559 | |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 1.69e-06 | 4 | 156 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 3.45e-05 | 9 | 156 | 3 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 3.45e-05 | 9 | 156 | 3 | GO:0000912 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 4.90e-05 | 10 | 156 | 3 | GO:0044837 | |
| Domain | GST_mu | 2.39e-08 | 5 | 157 | 4 | IPR003081 | |
| Domain | GST_N | 3.12e-05 | 22 | 157 | 4 | PF02798 | |
| Domain | GST_NTER | 3.12e-05 | 22 | 157 | 4 | PS50404 | |
| Domain | ABC_membrane | 4.48e-05 | 24 | 157 | 4 | PF00664 | |
| Domain | GST_C | 6.22e-05 | 26 | 157 | 4 | IPR004046 | |
| Domain | GST_C | 6.22e-05 | 26 | 157 | 4 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 7.25e-05 | 27 | 157 | 4 | IPR004045 | |
| Domain | ABC_TM1F | 8.41e-05 | 28 | 157 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 8.41e-05 | 28 | 157 | 4 | IPR011527 | |
| Domain | Spectrin_repeat | 9.69e-05 | 29 | 157 | 4 | IPR002017 | |
| Domain | SPEC | 1.44e-04 | 32 | 157 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.44e-04 | 32 | 157 | 4 | IPR018159 | |
| Domain | GST_CTER | 1.83e-04 | 34 | 157 | 4 | PS50405 | |
| Domain | Cadherin_2 | 2.17e-04 | 65 | 157 | 5 | PF08266 | |
| Domain | Cadherin_N | 2.17e-04 | 65 | 157 | 5 | IPR013164 | |
| Domain | AAA | 2.18e-04 | 144 | 157 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 2.18e-04 | 144 | 157 | 7 | IPR003593 | |
| Domain | Cadherin_tail | 2.56e-04 | 37 | 157 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 2.56e-04 | 37 | 157 | 4 | IPR031904 | |
| Domain | Glutathione-S-Trfase_C-like | 3.14e-04 | 39 | 157 | 4 | IPR010987 | |
| Domain | - | 3.14e-04 | 39 | 157 | 4 | 1.20.1050.10 | |
| Domain | Cadherin_CS | 3.18e-04 | 109 | 157 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 3.86e-04 | 113 | 157 | 6 | PS00232 | |
| Domain | Cadherin | 3.86e-04 | 113 | 157 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 4.05e-04 | 114 | 157 | 6 | PS50268 | |
| Domain | - | 4.05e-04 | 114 | 157 | 6 | 2.60.40.60 | |
| Domain | DC_STAMP-like | 4.17e-04 | 4 | 157 | 2 | IPR012858 | |
| Domain | DC_STAMP | 4.17e-04 | 4 | 157 | 2 | PF07782 | |
| Domain | ABC_transporter_CS | 4.19e-04 | 42 | 157 | 4 | IPR017871 | |
| Domain | Cadherin_C | 4.19e-04 | 42 | 157 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 4.19e-04 | 42 | 157 | 4 | PF16492 | |
| Domain | CA | 4.24e-04 | 115 | 157 | 6 | SM00112 | |
| Domain | Cadherin-like | 4.45e-04 | 116 | 157 | 6 | IPR015919 | |
| Domain | Cadherin | 4.87e-04 | 118 | 157 | 6 | IPR002126 | |
| Domain | ABC_tran | 7.01e-04 | 48 | 157 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.01e-04 | 48 | 157 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 7.59e-04 | 49 | 157 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 8.19e-04 | 50 | 157 | 4 | IPR003439 | |
| Domain | ACTININ_2 | 9.12e-04 | 23 | 157 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.12e-04 | 23 | 157 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.12e-04 | 23 | 157 | 3 | IPR001589 | |
| Domain | - | 1.03e-03 | 6 | 157 | 2 | 3.90.1290.10 | |
| Domain | Plectin | 1.43e-03 | 7 | 157 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.43e-03 | 7 | 157 | 2 | IPR001101 | |
| Domain | PAP_assoc | 1.43e-03 | 7 | 157 | 2 | PF03828 | |
| Domain | PAP_assoc | 1.43e-03 | 7 | 157 | 2 | IPR002058 | |
| Domain | PLEC | 1.43e-03 | 7 | 157 | 2 | SM00250 | |
| Domain | CH | 2.18e-03 | 65 | 157 | 4 | SM00033 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 6.94e-06 | 19 | 95 | 4 | M47809 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 1.55e-05 | 23 | 95 | 4 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 1.85e-05 | 24 | 95 | 4 | M47487 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 3.57e-05 | 92 | 95 | 6 | MM15823 | |
| Pathway | WP_NRF2_PATHWAY | 4.58e-05 | 141 | 95 | 7 | M39454 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 9.66e-05 | 36 | 95 | 4 | M1443 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.20e-04 | 38 | 95 | 4 | MM14600 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.14e-04 | 44 | 95 | 4 | M11911 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 2.66e-04 | 19 | 95 | 3 | M10959 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 3.52e-04 | 50 | 95 | 4 | M1840 | |
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 18551009 | ||
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 19856098 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK1 POLR1A RARS1 SHMT2 MCM6 PSMD5 CMSS1 SMC2 EPB41L3 MTPAP RLF TGM2 URB1 ARHGEF40 ANLN WDR6 TUBGCP3 ASS1 PDCD11 DDX23 GSDMA MACF1 SCRIB PLEC | 1.75e-08 | 1353 | 161 | 24 | 29467282 |
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 9.74e-08 | 3 | 161 | 3 | 32574561 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 9452477 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 16549767 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8471052 | ||
| Pubmed | Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. | 3.88e-07 | 4 | 161 | 3 | 8317488 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 22406107 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 8373352 | ||
| Pubmed | Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. | 3.88e-07 | 4 | 161 | 3 | 19151192 | |
| Pubmed | APOBEC3D POLR1A PCDHGA3 LAMA5 APOB CMSS1 EPB41L3 MTPAP NELL1 LRRC1 NEMF MACF1 PLEC | 6.07e-07 | 496 | 161 | 13 | 31343991 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAD51 KMT2B VWA8 ATP13A1 TMEM8B LAMA5 PAPLN URB1 ARHGEF40 IER5L FAM83F PKD1 TXNRD3 NAV1 PDCD11 HMGXB3 PLEC HECTD1 IQGAP3 | 9.73e-07 | 1105 | 161 | 19 | 35748872 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RARS1 VPS13C SERPINF1 OLFM4 LAMA5 SHMT2 ABCC11 ITGA1 SMC2 B4GALT1 GSTM2 TGM2 PTPRJ FAM151A ASS1 PKD1 UMOD FGG | 1.26e-06 | 1016 | 161 | 18 | 19056867 |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 17575307 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 1530570 | ||
| Pubmed | DMXL2 LUC7L3 PAPLN PATL1 SMC2 MAP3K6 TGM2 ARHGEF40 WDR6 TUBGCP3 NEMF SCRIB IQGAP3 SEMA3E | 2.24e-06 | 650 | 161 | 14 | 38777146 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | DMXL2 PSMD5 INPP5F SMC2 EPB41L3 TRIM3 DARS2 GSTM2 SYNE2 NAV1 MACF1 SCRIB | 3.95e-06 | 498 | 161 | 12 | 36634849 |
| Pubmed | Pkd1 and Pkd2 are required for normal placental development. | 5.36e-06 | 8 | 161 | 3 | 20862291 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 15802388 | ||
| Pubmed | RARS1 LUC7L3 VWA8 ATP13A1 SHMT2 B3GALT6 APOB PATL1 CMSS1 MTPAP TRIM3 TGM2 ARHGEF40 WDR6 TUBGCP3 NEMF PDCD11 DDX23 MCAT PLEC | 5.95e-06 | 1371 | 161 | 20 | 36244648 | |
| Pubmed | 8.36e-06 | 102 | 161 | 6 | 10231032 | ||
| Pubmed | 1.10e-05 | 30 | 161 | 4 | 20200426 | ||
| Pubmed | HK1 VWA8 SHMT2 MCM6 SMC2 COG8 NUP54 WDR6 TUBGCP3 LRRC1 DDX23 BZW1 | 1.28e-05 | 560 | 161 | 12 | 35241646 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 1.65e-05 | 68 | 161 | 5 | 11230163 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | LUC7L3 SMC2 EPB41L3 ANLN TUBGCP3 LRRC1 MED12L DDX23 MACF1 BZW1 SCRIB PLEC | 1.87e-05 | 582 | 161 | 12 | 20467437 |
| Pubmed | DMXL2 HK1 VWA8 ATP13A1 C1orf43 SHMT2 EPB41L3 DARS2 URB1 SNX6 WDR6 TRABD SYNE2 TUBGCP3 LRRC1 EFR3B PDCD11 DDX23 MACF1 SCRIB | 1.93e-05 | 1487 | 161 | 20 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POLR1A LUC7L3 TMEM8B VPS13C ENC1 FRMPD1 PATL1 SFMBT2 B4GALT1 RLF PTPRJ LRRC1 NEMF ASS1 NAV1 CDYL2 MACF1 CATSPERG HECTD1 CFAP69 | 1.97e-05 | 1489 | 161 | 20 | 28611215 |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 2689439 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22827961 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 38165568 | ||
| Pubmed | Structure of human glutathione S-transferase class Mu genes. | 2.13e-05 | 2 | 161 | 2 | 2006920 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 3174634 | ||
| Pubmed | MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function. | 2.13e-05 | 2 | 161 | 2 | 35121660 | |
| Pubmed | The Tumor Suppressor SCRIB is a Negative Modulator of the Wnt/β-Catenin Signaling Pathway. | 2.13e-05 | 2 | 161 | 2 | 31513346 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24048194 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8909248 | ||
| Pubmed | DNA methylation is associated with altered gene expression in AMD. | 2.13e-05 | 2 | 161 | 2 | 22410570 | |
| Pubmed | Identification of a variant associated with adult-type hypolactasia. | 2.13e-05 | 2 | 161 | 2 | 11788828 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12486119 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24399650 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18791038 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17911653 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23675469 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 29244742 | ||
| Pubmed | Genomic organization and characterization of the promoter region of murine GSTM2 gene. | 2.13e-05 | 2 | 161 | 2 | 11404019 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 6500576 | ||
| Pubmed | Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice. | 2.13e-05 | 2 | 161 | 2 | 25353084 | |
| Pubmed | Convergent adaptation of human lactase persistence in Africa and Europe. | 2.13e-05 | 2 | 161 | 2 | 17159977 | |
| Pubmed | Cloning and expression of a novel Mu class murine glutathione transferase isoenzyme. | 2.13e-05 | 2 | 161 | 2 | 12069689 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20002670 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31278057 | ||
| Pubmed | Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. | 2.13e-05 | 2 | 161 | 2 | 11688999 | |
| Pubmed | A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. | 2.13e-05 | 2 | 161 | 2 | 15579506 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18692819 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12192076 | ||
| Pubmed | GSTM1 and GSTM5 Genetic Polymorphisms and Expression in Age-Related Macular Degeneration. | 2.13e-05 | 2 | 161 | 2 | 25897651 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11483364 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.18e-05 | 72 | 161 | 5 | 10380929 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RARS1 CMSS1 SMC2 MTPAP NUP54 GSTM1 GSTM2 TGM2 FAM83F ANLN WDR6 ASS1 NAV1 PDCD11 GSDMA SCRIB PLEC IQGAP3 | 2.30e-05 | 1257 | 161 | 18 | 36526897 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.49e-05 | 74 | 161 | 5 | 10817752 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 2.59e-05 | 37 | 161 | 4 | 27565344 | |
| Pubmed | 3.02e-05 | 77 | 161 | 5 | 10835267 | ||
| Pubmed | RARS1 LAMA5 APOB CMSS1 MTPAP DARS2 ARHGEF40 SNX6 ANLN WDR6 SYNE2 NEMF ASS1 PDCD11 MACF1 BZW1 HECTD1 POFUT2 | 3.46e-05 | 1297 | 161 | 18 | 33545068 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | POLR1A RARS1 ATP13A1 C1orf43 MCM6 CMSS1 DARS2 COG8 URB1 ARHGEF40 TRABD BZW1 SCRIB HECTD1 IQGAP3 | 3.49e-05 | 942 | 161 | 15 | 31073040 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.63e-05 | 80 | 161 | 5 | 10716726 | |
| Pubmed | HK1 PCDHGA10 PCDHGA5 PCDHGA3 PCDHGA1 ABCC5 APOB SMC2 EPB41L3 SFMBT2 NUP54 NEK2 SYNE2 PLXNA4 DDX23 MACF1 PLEC CFAP69 POFUT2 | 4.17e-05 | 1442 | 161 | 19 | 35575683 | |
| Pubmed | 4.60e-05 | 202 | 161 | 7 | 24639526 | ||
| Pubmed | 5.43e-05 | 87 | 161 | 5 | 33711283 | ||
| Pubmed | HK1 POLR1A MCM6 EPB41L3 URB1 WDR6 SYNE2 PDCD11 DDX23 MACF1 PLEC HECTD1 | 5.70e-05 | 653 | 161 | 12 | 22586326 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 16842493 | ||
| Pubmed | Purification and characterization of glutathione S-transferase of murine ovary and testis. | 6.37e-05 | 3 | 161 | 2 | 8442656 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 8512323 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 17237400 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 18033323 | ||
| Pubmed | Homeobox genes Gsx1 and Gsx2 differentially regulate telencephalic progenitor maturation. | 6.37e-05 | 3 | 161 | 2 | 21205889 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 8473333 | ||
| Pubmed | Genetic susceptibility, residential radon, and lung cancer in a radon prone area. | 6.37e-05 | 3 | 161 | 2 | 24852519 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 18952287 | ||
| Pubmed | Biosynthesis of 14,15-hepoxilins in human l1236 Hodgkin lymphoma cells and eosinophils. | 6.37e-05 | 3 | 161 | 2 | 21046276 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 16002077 | ||
| Pubmed | Gsh-1: a novel murine homeobox gene expressed in the central nervous system. | 6.37e-05 | 3 | 161 | 2 | 8589431 | |
| Pubmed | Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines. | 6.37e-05 | 3 | 161 | 2 | 27466493 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 27321929 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 37845212 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 10587441 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | HK1 LUC7L3 DIS3L MCM6 SMC2 TULP2 SNX6 WDR6 PDCD11 DDX23 CATSPERG USH2A | 7.27e-05 | 670 | 161 | 12 | 22990118 |
| Pubmed | Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth. | 8.93e-05 | 19 | 161 | 3 | 37541847 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | THEMIS2 TDRD5 OPN3 C1orf43 SYT6 B3GALT6 GPR52 DCST2 DARS2 RLF NEK2 TAS1R2 BRINP2 MACF1 USH2A | 9.58e-05 | 1031 | 161 | 15 | 16710414 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RARS1 LUC7L3 VWA8 SHMT2 MCM6 PATL1 CMSS1 SMC2 DARS2 SYNE2 NEMF ASS1 NAV1 DDX23 MACF1 BZW1 PLEC HECTD1 | 1.05e-04 | 1415 | 161 | 18 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK1 POLR1A RARS1 LUC7L3 ATP13A1 VPS13C SHMT2 MCM6 APOB SMC2 EPB41L3 DARS2 URB1 WDR6 NEMF PDCD11 BZW1 IQGAP3 | 1.14e-04 | 1425 | 161 | 18 | 30948266 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | HK1 POLR1A SHMT2 MCM6 PSMD5 SMC2 MTPAP DARS2 ANLN PDCD11 SCRIB IQGAP3 | 1.16e-04 | 704 | 161 | 12 | 29955894 |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 29656212 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 14688336 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 19889946 | ||
| Pubmed | Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting. | 1.27e-04 | 4 | 161 | 2 | 30545844 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 18581889 | ||
| Pubmed | p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. | 1.27e-04 | 4 | 161 | 2 | 17292829 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 35041705 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 18003909 | ||
| Interaction | GSTM2 interactions | 6.57e-07 | 22 | 158 | 5 | int:GSTM2 | |
| Interaction | OBSL1 interactions | APOBEC3D POLR1A LUC7L3 LAMA5 SHMT2 MCM6 CMSS1 MTPAP NUP54 NELL1 ADPRH URB1 ATG3 SYNE2 LRRC1 NEMF PDCD11 DDX23 MACF1 SCRIB PLEC HECTD1 | 2.25e-06 | 902 | 158 | 22 | int:OBSL1 |
| Interaction | GSTM5 interactions | 4.64e-06 | 15 | 158 | 4 | int:GSTM5 | |
| Interaction | GSTM1 interactions | 4.64e-06 | 15 | 158 | 4 | int:GSTM1 | |
| Cytoband | 1p13.3 | 1.05e-04 | 69 | 161 | 4 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 1.07e-04 | 211 | 161 | 6 | chr1p13 | |
| Cytoband | 20q13.2-q13.3 | 1.21e-04 | 5 | 161 | 2 | 20q13.2-q13.3 | |
| Cytoband | 5q35.1 | 3.26e-04 | 38 | 161 | 3 | 5q35.1 | |
| Cytoband | 5q31 | 7.44e-04 | 115 | 161 | 4 | 5q31 | |
| Cytoband | 19q13.1 | 9.71e-04 | 55 | 161 | 3 | 19q13.1 | |
| Cytoband | 2q21 | 1.08e-03 | 14 | 161 | 2 | 2q21 | |
| GeneFamily | ATP binding cassette subfamily C | 9.22e-07 | 13 | 111 | 4 | 807 | |
| GeneFamily | Glutathione S-transferases | 1.54e-05 | 25 | 111 | 4 | 567 | |
| GeneFamily | Clustered protocadherins | 6.44e-04 | 64 | 111 | 4 | 20 | |
| GeneFamily | Non-canonical poly(A) polymerases | 7.69e-04 | 7 | 111 | 2 | 1318 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.02e-03 | 8 | 111 | 2 | 939 | |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP | 9.83e-06 | 169 | 160 | 8 | M6700 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 2.05e-05 | 187 | 160 | 8 | M6807 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN | 3.19e-05 | 199 | 160 | 8 | M9423 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP | 3.31e-05 | 200 | 160 | 8 | M3743 | |
| Coexpression | GSE3039_B2_VS_B1_BCELL_DN | 3.31e-05 | 200 | 160 | 8 | M6453 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP | 3.91e-05 | 102 | 160 | 6 | M6681 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 3.10e-08 | 189 | 161 | 9 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.46e-07 | 163 | 161 | 8 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 187 | 161 | 8 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 187 | 161 | 8 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 187 | 161 | 8 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 171 | 161 | 7 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 175 | 161 | 7 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-5|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.56e-06 | 182 | 161 | 7 | 9e48d5b634603bc7a8d29290202a311457678328 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.72e-06 | 183 | 161 | 7 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.26e-06 | 186 | 161 | 7 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 186 | 161 | 7 | f14722ecc832794dc267bf3f9b8a13274c3addc1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-06 | 196 | 161 | 7 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-06 | 196 | 161 | 7 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-06 | 196 | 161 | 7 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.45e-06 | 200 | 161 | 7 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.45e-06 | 200 | 161 | 7 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-05 | 152 | 161 | 6 | 0769857f25da2e6169420818e61d65e33b7277b1 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 2.48e-05 | 159 | 161 | 6 | 85501c636cd04f15ba1be24df1ba7ac909633ce8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 2.76e-05 | 162 | 161 | 6 | e088e66aabc307dde5d2b9aa295c34ef68155b1a | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-05 | 164 | 161 | 6 | 5638d95c7cc5e59c4a7bda30268a904a01861a5f | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-05 | 165 | 161 | 6 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.06e-05 | 165 | 161 | 6 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-05 | 171 | 161 | 6 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 173 | 161 | 6 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 4.12e-05 | 174 | 161 | 6 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 175 | 161 | 6 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-05 | 175 | 161 | 6 | bde785ff0c854646d7ab8571359e9d69a7bf013f | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 175 | 161 | 6 | 758a1796b823118ce52f989ef5e1076f8c8ac4c5 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 175 | 161 | 6 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.82e-05 | 179 | 161 | 6 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.97e-05 | 180 | 161 | 6 | f598bb9df0d784120847fada2d9a2a88b8b68cd1 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 4.97e-05 | 180 | 161 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.97e-05 | 180 | 161 | 6 | b4fa047f271c7b56940bdc85c912f50aa5b5ca82 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.13e-05 | 181 | 161 | 6 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.13e-05 | 181 | 161 | 6 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 181 | 161 | 6 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 182 | 161 | 6 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 183 | 161 | 6 | 92f54c267135cb5edbcacd26a0f29e62469bb7e5 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 183 | 161 | 6 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.45e-05 | 183 | 161 | 6 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 183 | 161 | 6 | 5c4f7d02ba3a3c4a22ac71302e7c9a47e205eef5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.45e-05 | 183 | 161 | 6 | 614a1c08cf6d01a4f1ed2fb816cd1a6e0c3207ce | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 183 | 161 | 6 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.79e-05 | 185 | 161 | 6 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.79e-05 | 185 | 161 | 6 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 187 | 161 | 6 | 74112df9b34051ae5cd2427ccfa3399eccff0076 | |
| ToppCell | facs-Bladder|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 187 | 161 | 6 | dd5ca59417fd1b388fd975f0f3e1f3245d66ebc5 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 187 | 161 | 6 | 214ce9b55fd6ce2fe7bd4cf4b1383517f5f0d759 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.33e-05 | 188 | 161 | 6 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.33e-05 | 188 | 161 | 6 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 6.33e-05 | 188 | 161 | 6 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 188 | 161 | 6 | e1f18c11e4848978ca7bbe9271917da14b3f0523 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 188 | 161 | 6 | 283a7a22db144e8f942904d4a38cac30874f6d9e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.33e-05 | 188 | 161 | 6 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.33e-05 | 188 | 161 | 6 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | normal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.52e-05 | 189 | 161 | 6 | 1d382f8eb998c6a30e09fddc9a427afc8f5f7323 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.52e-05 | 189 | 161 | 6 | b83fd81ecc5ef363be7435ee12cb7079e2434af7 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.52e-05 | 189 | 161 | 6 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | facs-Marrow-KLS|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 189 | 161 | 6 | 4214abfa07b047e256df43e472f9a835a18ed7a3 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.52e-05 | 189 | 161 | 6 | 3db4177d68cab4cd16842d2ebcaca28f69300e44 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 6.71e-05 | 190 | 161 | 6 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 6.71e-05 | 190 | 161 | 6 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.71e-05 | 190 | 161 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.91e-05 | 191 | 161 | 6 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 6.91e-05 | 191 | 161 | 6 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 6.91e-05 | 191 | 161 | 6 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.91e-05 | 191 | 161 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.91e-05 | 191 | 161 | 6 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.91e-05 | 191 | 161 | 6 | 5c0c44612b4cdbf89c0f1f219416374a7541f610 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 192 | 161 | 6 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 192 | 161 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.11e-05 | 192 | 161 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.31e-05 | 193 | 161 | 6 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.31e-05 | 193 | 161 | 6 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.31e-05 | 193 | 161 | 6 | 8ede7038a222c7e7ecaf7e86520823cf606cbee7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.31e-05 | 193 | 161 | 6 | 0e7d7adfaa7191e34038fcda6677561ae13934eb | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.53e-05 | 194 | 161 | 6 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.53e-05 | 194 | 161 | 6 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.53e-05 | 194 | 161 | 6 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.53e-05 | 194 | 161 | 6 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.53e-05 | 194 | 161 | 6 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.74e-05 | 195 | 161 | 6 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.74e-05 | 195 | 161 | 6 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.84e-05 | 121 | 161 | 5 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.96e-05 | 196 | 161 | 6 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 7.96e-05 | 196 | 161 | 6 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-05 | 196 | 161 | 6 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-05 | 196 | 161 | 6 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.19e-05 | 197 | 161 | 6 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.19e-05 | 197 | 161 | 6 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.42e-05 | 198 | 161 | 6 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 8.42e-05 | 198 | 161 | 6 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 8.42e-05 | 198 | 161 | 6 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | Severe-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.42e-05 | 198 | 161 | 6 | 8402421dc060926e968efe39a4e907f1e8ae5b1f | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.66e-05 | 199 | 161 | 6 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.66e-05 | 199 | 161 | 6 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 8.66e-05 | 199 | 161 | 6 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T|lymph-node_spleen / Manually curated celltypes from each tissue | 8.66e-05 | 199 | 161 | 6 | 28fc342d2d178ce33203a78eb9eedae54fa9c916 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.66e-05 | 199 | 161 | 6 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.66e-05 | 199 | 161 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| Computational | ROS metabolism. | 2.62e-05 | 22 | 87 | 4 | MODULE_310 | |
| Computational | Genes in the cancer module 101. | 5.90e-05 | 10 | 87 | 3 | MODULE_101 | |
| Computational | Genes in the cancer module 132. | 1.75e-04 | 14 | 87 | 3 | MODULE_132 | |
| Drug | Ethoxyquin | 3.21e-07 | 40 | 158 | 6 | ctd:D005015 | |
| Drug | EUK-189 | 3.81e-06 | 16 | 158 | 4 | ctd:C436526 | |
| Drug | oxidized glutathione | 4.40e-06 | 227 | 158 | 10 | CID000000975 | |
| Drug | Clch2cosg | 6.33e-06 | 18 | 158 | 4 | CID000163913 | |
| Drug | C14791 | 6.33e-06 | 18 | 158 | 4 | CID011954044 | |
| Drug | C14793 | 6.33e-06 | 18 | 158 | 4 | CID011954046 | |
| Drug | C14803 | 6.33e-06 | 18 | 158 | 4 | CID011954054 | |
| Drug | C14805 | 6.33e-06 | 18 | 158 | 4 | CID011954056 | |
| Drug | C14804 | 6.33e-06 | 18 | 158 | 4 | CID011954055 | |
| Drug | C14806 | 6.33e-06 | 18 | 158 | 4 | CID011954057 | |
| Drug | C14848 | 6.33e-06 | 18 | 158 | 4 | CID011954067 | |
| Drug | C14856 | 6.33e-06 | 18 | 158 | 4 | CID011954069 | |
| Drug | C14855 | 6.33e-06 | 18 | 158 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 6.33e-06 | 18 | 158 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 6.33e-06 | 18 | 158 | 4 | CID000188517 | |
| Drug | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | 6.46e-06 | 6 | 158 | 3 | ctd:C042630 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 9.92e-06 | 20 | 158 | 4 | CID011954072 | |
| Drug | C14865 | 9.92e-06 | 20 | 158 | 4 | CID011954073 | |
| Drug | S-(formylmethyl)glutathione | 2.13e-05 | 24 | 158 | 4 | CID011954074 | |
| Drug | glutathione reduced | GSX1 HK1 ABCC5 ABCC11 GSX2 SMC2 ITGB7 ABCC6 GSTM1 GSTM2 GSTM4 GSTM5 TGM2 ABCC12 | 2.25e-05 | 534 | 158 | 14 | CID000000745 |
| Drug | AC1Q608X | 4.01e-05 | 28 | 158 | 4 | CID000128466 | |
| Drug | AC1L33DC | 4.01e-05 | 28 | 158 | 4 | CID000133757 | |
| Drug | oltipraz | 4.34e-05 | 56 | 158 | 5 | ctd:C026209 | |
| Drug | 2-BHA | 4.63e-05 | 29 | 158 | 4 | CID000006932 | |
| Drug | Glutathione S-(2,4 Dinitrobenzene) | 4.79e-05 | 2 | 158 | 2 | DB02458 | |
| Drug | oltipraz | 4.91e-05 | 137 | 158 | 7 | CID000047318 | |
| Drug | ethacrynic acid | 5.14e-05 | 138 | 158 | 7 | CID000003278 | |
| Drug | Dcvg | 6.07e-05 | 31 | 158 | 4 | CID006437359 | |
| Drug | o-dinitrobenzene | 6.07e-05 | 31 | 158 | 4 | CID000010707 | |
| Drug | PenCB | 6.57e-05 | 61 | 158 | 5 | CID000036188 | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 4833_UP | |
| Drug | sulfobromophthalein | 8.34e-05 | 103 | 158 | 6 | CID000005345 | |
| Drug | ss,ss-carotene | 8.34e-05 | 201 | 158 | 8 | CID000000573 | |
| Drug | m-toluidine | 8.80e-05 | 34 | 158 | 4 | CID000007934 | |
| Drug | Lyndiol | 8.80e-05 | 34 | 158 | 4 | CID000082149 | |
| Drug | AC1NSK22 | 9.60e-05 | 66 | 158 | 5 | CID005311131 | |
| Drug | dimethoxystrychnine | 9.89e-05 | 35 | 158 | 4 | CID000009649 | |
| Drug | Dixan | 9.89e-05 | 35 | 158 | 4 | CID000010404 | |
| Drug | Glutathione | 1.11e-04 | 36 | 158 | 4 | DB00143 | |
| Drug | CAS 81-11-8 | 1.20e-04 | 110 | 158 | 6 | CID000006668 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 3.65e-09 | 5 | 155 | 4 | DOID:0050451 (implicated_via_orthology) | |
| Disease | mental development measurement | 8.50e-06 | 25 | 155 | 4 | EFO_0008230 | |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 2.74e-05 | 2 | 155 | 2 | OBA_2041806 | |
| Disease | 3,7-dimethylurate measurement | 2.74e-05 | 2 | 155 | 2 | EFO_0800949 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 3.69e-05 | 71 | 155 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | Degenerative Diseases, Central Nervous System | 5.22e-05 | 39 | 155 | 4 | C0270715 | |
| Disease | Neurodegenerative Disorders | 5.22e-05 | 39 | 155 | 4 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 5.22e-05 | 39 | 155 | 4 | C0751733 | |
| Disease | obesity (implicated_via_orthology) | 1.48e-04 | 215 | 155 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Sarcosine measurement | 2.33e-04 | 23 | 155 | 3 | EFO_0021668 | |
| Disease | glutathione S-transferase Mu 1 measurement | 2.71e-04 | 5 | 155 | 2 | EFO_0801638 | |
| Disease | erythrocyte aggregation | 4.06e-04 | 6 | 155 | 2 | EFO_0803375 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 4.23e-04 | 28 | 155 | 3 | DOID:0050866 (is_implicated_in) | |
| Disease | D dimer measurement | 5.20e-04 | 30 | 155 | 3 | EFO_0004507 | |
| Disease | anxiety, vitamin D measurement | 5.66e-04 | 7 | 155 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | obsolete_red blood cell distribution width | THEMIS2 HK1 KMT2B POLR1A PCDHGA5 ENC1 ABCC5 PAPLN MCM6 APOB TFR2 NEK2 METTL25B IER5L ANLN SYNE2 LRRC23 | 7.49e-04 | 1347 | 155 | 17 | EFO_0005192 |
| Disease | lactase-phlorizin hydrolase measurement | 7.52e-04 | 8 | 155 | 2 | EFO_0801753 | |
| Disease | benign neoplasm (implicated_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 8.22e-04 | 35 | 155 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | vesicoureteral reflux | 1.05e-03 | 38 | 155 | 3 | EFO_0007536 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.31e-03 | 41 | 155 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | kidney cancer (implicated_via_orthology) | 1.46e-03 | 11 | 155 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | GABRP LUC7L3 LAMA5 SFMBT2 FBXL4 NELL1 ASS1 PLXNA4 NAV1 USH2A | 1.67e-03 | 619 | 155 | 10 | EFO_0003923, EFO_0004531 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.72e-03 | 45 | 155 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | lymphocyte count | THEMIS2 PCDHGA10 OPN3 PCDHGA5 PCDHGA3 PCDHGA1 ENC1 OLFM4 ABCC5 GSX2 ITGA1 ITGB7 TFR2 PTPRJ MED12L PLEC PGBD2 | 1.84e-03 | 1464 | 155 | 17 | EFO_0004587 |
| Disease | osteitis deformans | 2.06e-03 | 13 | 155 | 2 | EFO_0004261 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.19e-03 | 49 | 155 | 3 | EFO_0021897 | |
| Disease | diabetic retinopathy (is_implicated_in) | 2.33e-03 | 50 | 155 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | dystonia (is_implicated_in) | 2.39e-03 | 14 | 155 | 2 | DOID:543 (is_implicated_in) | |
| Disease | femoral neck bone geometry | 2.39e-03 | 14 | 155 | 2 | EFO_0004511 | |
| Disease | apolipoprotein B measurement | 2.74e-03 | 663 | 155 | 10 | EFO_0004615 | |
| Disease | alkaline phosphatase measurement | ATP13A1 TMEM176A PAPLN SLC39A4 APOB ITGA1 TULP2 WDR91 PTPRJ PKD1 CDYL2 GSDMA MACF1 | 2.79e-03 | 1015 | 155 | 13 | EFO_0004533 |
| Disease | mean platelet volume | DIS3L PCDHGA10 PCDHGA5 PCDHGA3 PCDHGA1 ABCC5 GSTM1 GSTM2 PTPRJ TRABD SYNE2 PLEC CATSPERG | 2.91e-03 | 1020 | 155 | 13 | EFO_0004584 |
| Disease | phospholipids in medium HDL measurement | 3.05e-03 | 55 | 155 | 3 | EFO_0022295 | |
| Disease | Diabetic Angiopathies | 3.13e-03 | 16 | 155 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 3.13e-03 | 16 | 155 | 2 | C0025945 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 3.21e-03 | 56 | 155 | 3 | EFO_0022279 | |
| Disease | Dystonia, Limb | 3.54e-03 | 17 | 155 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 3.54e-03 | 17 | 155 | 2 | C0393610 | |
| Disease | low density lipoprotein particle size measurement | 3.55e-03 | 58 | 155 | 3 | EFO_0008593 | |
| Disease | total lipids in medium HDL measurement | 3.55e-03 | 58 | 155 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 3.55e-03 | 58 | 155 | 3 | EFO_0022267 | |
| Disease | multiple myeloma (is_implicated_in) | 3.73e-03 | 59 | 155 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | cholesterol in medium HDL measurement | 3.73e-03 | 59 | 155 | 3 | EFO_0021903 | |
| Disease | Dystonia, Paroxysmal | 3.97e-03 | 18 | 155 | 2 | C0393588 | |
| Disease | phospholipids in HDL measurement | 4.09e-03 | 61 | 155 | 3 | EFO_0022293 | |
| Disease | diet measurement, HOMA-B | 4.42e-03 | 19 | 155 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | optic disc size measurement | 4.65e-03 | 205 | 155 | 5 | EFO_0004832 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.72e-03 | 128 | 155 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.72e-03 | 128 | 155 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.72e-03 | 128 | 155 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.72e-03 | 128 | 155 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.72e-03 | 128 | 155 | 4 | C0007134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FYIRIYSRDSSELLE | 486 | Q8NAT2 | |
| KRLAFDITYTLEYSR | 886 | Q6ZRH7 | |
| ALYGRIYVEARSRIL | 226 | P28222 | |
| SADLVHYLRLSRDYL | 221 | Q96L58 | |
| VTLVYYLAGRDLSRL | 36 | P15291 | |
| LRLYDRYSTVQAART | 61 | P12645 | |
| ATLDYERSRTHYITV | 196 | Q96JP9 | |
| VTLTISAARLYYYRD | 126 | Q96AK3 | |
| VERTYREDALRYTLD | 36 | Q8TER5 | |
| LDYRRYAETLFDILV | 61 | Q7L1Q6 | |
| LYEDRRSSALYFAVV | 406 | Q96Q27 | |
| FLSLVYLYREAQARS | 1066 | Q9HD20 | |
| ARYVRTDYTLLDVLE | 51 | Q96QA5 | |
| GSIRYNYLLDVLERS | 231 | P22455 | |
| DYYSSRRLVIELEEL | 101 | Q9BQ75 | |
| TFLLRTYAYLENRVR | 291 | Q6PIY7 | |
| LYALLAADQDTSYRI | 1431 | Q8TDJ6 | |
| SRVYELRNEIYIFLV | 311 | Q8TCP9 | |
| ALYEDRYLLGTSLAR | 81 | P00966 | |
| EDAILQTRTYDLYIT | 191 | Q9NT62 | |
| YALLIVDSATALYRT | 216 | Q06609 | |
| RLYDLRADREVAIYS | 306 | O14775 | |
| YYHLLTTRDLDREET | 401 | Q9Y5G8 | |
| IIAGTSAYARLIDYA | 221 | P34897 | |
| YAVLRNITELRRIYS | 411 | P0C881 | |
| YAVLRNITELRRIYS | 411 | B2RC85 | |
| SLLLDVEDYERRYLL | 531 | Q86TB9 | |
| SIEDARTALQLYRKY | 1136 | Q504Q3 | |
| ESIDRVYSLDDIRRY | 561 | Q14566 | |
| TTDLLINFRYLVRDY | 1211 | Q12913 | |
| TANLREYARYVLRTI | 1236 | Q86YW9 | |
| YDRIIDRTNTTLYIV | 71 | P51955 | |
| DYEYVILNILRFRTD | 126 | O60524 | |
| AIRLLLEYTDSSYVE | 16 | P46439 | |
| DRDLLYSIDAYRSQR | 666 | Q9NQW6 | |
| AIVSLIYIERLVSYA | 211 | Q5T2Q4 | |
| RLLSVAERSYYLEKA | 81 | Q12766 | |
| LLSYRDVQDYSAIIE | 281 | O95382 | |
| YLSRLRRIEIATYLN | 226 | Q9BZM3 | |
| LLRSYIHLRYVDISE | 86 | Q53EV4 | |
| ERSGVEYRLLQAAYL | 301 | Q9HCM2 | |
| SIDSYYRLVIHRALD | 401 | Q9Y5H3 | |
| IYALRSFDYETLRQL | 561 | O95206 | |
| RQLRLSIDYALTGSY | 341 | Q9Y2G0 | |
| AAVDYLLYRLIFSVS | 311 | Q9H295 | |
| SIRLLLEYTDSSYEE | 16 | P28161 | |
| YLSRLRRIEIATYLN | 171 | Q9H4S2 | |
| RISLARAVYSDRQIY | 641 | Q96J66 | |
| YEEALELAAYVRRLE | 171 | Q96MW5 | |
| NYYVRLIDTLLAASI | 1471 | P09848 | |
| YERDFLRYLQSLLAE | 81 | O95232 | |
| ELREYYRLLSVLHSQ | 331 | Q96CW5 | |
| ALRRILRGEELTYDY | 2676 | Q9UMN6 | |
| YLTRLRRYEIAVNLD | 211 | P50222 | |
| LTRVLALYRSILDAY | 21 | Q96FB5 | |
| ARRTSIYHYLFEIVE | 216 | Q8WVL7 | |
| AYYEAALLQLRVTEA | 1016 | O15230 | |
| SSELLYIYGALDSRV | 336 | Q9NVV4 | |
| AARILRYTDFDTLIY | 461 | Q6NUT2 | |
| DVLENRYLVLSRCTY | 531 | Q9BUQ8 | |
| RYLVLSRCTYVVLDE | 536 | Q9BUQ8 | |
| YEADLQYRVTLDSLR | 716 | P56199 | |
| IRTHYDRLVDEYSLN | 721 | P19367 | |
| YIIYFLLESSRVLDN | 281 | Q9Y2T5 | |
| YASSRREAYLLLQLF | 996 | Q86VI3 | |
| LESSGLRDEIRYHYI | 116 | Q92832 | |
| IYRYARSLEELLLDA | 31 | Q9BTT6 | |
| YEAISLLNSERYARL | 5761 | Q9UPN3 | |
| GLVLAYRLSVEIYDR | 741 | P26010 | |
| AVRSEERYYIDADLL | 446 | Q7Z3B4 | |
| YGSVLLLAAVSLDRY | 161 | Q96RI0 | |
| YYRLVTATSLDREQI | 401 | Q9Y5H0 | |
| TIYYLARLLEADCRV | 266 | P51582 | |
| YAAARRVLGYDLLEL | 91 | Q8IVS2 | |
| ARALYSDRSIYILDD | 696 | O15440 | |
| TLTVLAYERYIRVVH | 131 | Q9H1Y3 | |
| ILTHDSSIRYLQEIY | 126 | P02679 | |
| STILEYRDQISKYAR | 561 | O95876 | |
| ALLRSEYQADYESLR | 1596 | P04114 | |
| LEVTARAITYYLDVS | 71 | Q9ULT8 | |
| YLRYQEALSELATAV | 176 | Q9BWL3 | |
| RLEVNSSLLEYYTEL | 206 | Q9UKA2 | |
| LAARAVDRTRVYYRL | 556 | Q8WW52 | |
| IYSRLRKANITDVDY | 411 | Q96LA6 | |
| LCFRESYDRLYLDVV | 461 | Q96SL1 | |
| YFALALEEQYSISRL | 221 | Q5SYB0 | |
| LIERYAINIYLSDRI | 96 | Q8N4A0 | |
| EARTRATTYYLADRR | 521 | Q8TF46 | |
| ALRLREENRLYASYV | 66 | P0CW27 | |
| LRYQYLEELVSSRER | 46 | O60519 | |
| TERVYVRELYTVLLG | 506 | P10911 | |
| LAIAVDRYVTIFYAL | 136 | P41968 | |
| EVLELLLDYAYSSRV | 96 | O14682 | |
| LLDYAYSSRVIINEE | 101 | O14682 | |
| EQERISYLYNVLLSR | 536 | Q5T1A1 | |
| RYSLRLLRAVVYLED | 481 | A5D8W1 | |
| RLRSGLYSAVIVYDE | 96 | Q13115 | |
| LQVYSYRRLGEEALS | 496 | Q8IZD6 | |
| RDVDVLLLLSNSAYY | 636 | Q9Y2H2 | |
| TRYYLCLQLRDDIVS | 201 | Q9Y2J2 | |
| VSYVLRNARQLYLSE | 36 | Q5T953 | |
| RLAQYTIERYFTLVT | 206 | O00591 | |
| YSLALVTVLNEYERA | 2611 | P98161 | |
| VETLYRYRSDLEIIF | 561 | O14829 | |
| YYRLVTERTLDRELI | 401 | Q9Y5H4 | |
| YLTNRLAEYLVERSG | 1566 | Q8NEY1 | |
| ALRYLYGSDQLVVRI | 306 | Q9BQG1 | |
| SLRYDYETETLIVRI | 236 | Q5T7P8 | |
| AAYLLYAFTRIRSIA | 531 | P54136 | |
| NLRHRYYAVDEITIS | 501 | O75445 | |
| TEALRLQYRYLDLRS | 166 | Q6PI48 | |
| GSRLAEYSVNIRYLL | 536 | Q96JX3 | |
| YAEVLDLRRLYSNDI | 1591 | O95602 | |
| SINSLLERYDTYRDI | 1111 | Q8WXH0 | |
| YIRDYTLLVTSGAAI | 76 | Q96HP8 | |
| LSGAASRRRYLLYDV | 36 | Q9Y2G5 | |
| LSLARAVYRKAAVYL | 761 | O95255 | |
| AIRLLLEYTDSSYEE | 16 | Q03013 | |
| AIRLLLEYTDSSYEE | 16 | P09488 | |
| GERSSEYLRALFVYE | 141 | Q9H6Y7 | |
| RYVARLSAAAVLYLS | 91 | Q6P5W5 | |
| IYRYSRSLEELLLDA | 31 | Q14160 | |
| ILDDAIVQRLIYYAS | 46 | Q7Z745 | |
| ISLARAVYSDRQLYL | 611 | Q96J65 | |
| DLLLYINARELRITY | 311 | Q6UX06 | |
| LYAISEEVDLYRQLS | 291 | Q8NEG4 | |
| ASTLIRQVLDAVYYL | 121 | Q8IU85 | |
| VARSAYEIIRDYSLL | 1841 | O60287 | |
| EYLRERFVAAALSYI | 266 | Q9C0B6 | |
| LEYRNRLEETARALY | 331 | P54922 | |
| LDYSYLIGRLSSDRR | 311 | Q8N8U2 | |
| VDLLAFRRYIACVYL | 511 | Q6P3X8 | |
| VINSYLLAERDLYLE | 571 | P21980 | |
| YYQRLEIVEAAIRTL | 41 | Q96B21 | |
| RTSIIEAQYLRYHDI | 436 | Q14690 | |
| YLYLETSDSLQRFLL | 306 | O00295 | |
| YLSKESEVLIYARRD | 121 | Q8TBF5 | |
| TYSNTLYLADEIIIR | 401 | P07911 | |
| AEQRTESIIHRALYY | 96 | P36955 | |
| ESIIHRALYYDLISS | 101 | P36955 | |
| YLLEVYRLAIQSFAS | 96 | Q13129 | |
| TLLIYNLRARDEGSY | 1186 | O95428 | |
| LHRTIVSERDVYLTY | 251 | Q9H4I3 | |
| ATVEELTDTFYYRLR | 526 | Q5TEJ8 | |
| YNDYLSRLTVVVLRA | 341 | X6R8R1 | |
| LRLRYVGLEDTESYD | 216 | Q5VUG0 | |
| LERSLEAYRTVEELY | 401 | Q8IZM8 | |
| IEAVGYLYRSVDLRV | 1066 | Q6P2S7 | |
| YLYRSVDLRVIHLGS | 1071 | Q6P2S7 | |
| YAIDSVLEVHIRRYT | 376 | Q709C8 | |
| VLAIRSRYVLEAAVY | 251 | A6NDV4 | |
| SYDYVRRRLTAEDLF | 3776 | Q15149 | |
| RLLAVTDTGALYLYD | 361 | Q9NNW5 | |
| GLRLIYYSVAAALTD | 61 | A0A0A0MS04 | |
| SRLYIAYQFLLAEDT | 231 | O95347 | |
| ILRLSGERVVYSVYS | 376 | Q8TE23 | |
| AKDLLYRRSRSLVDY | 306 | Q9UNH7 | |
| ALVYRLIRDARYAEA | 16 | Q86WT1 | |
| RLSLREKAVAYVNSY | 261 | Q86VQ6 | |
| VRYRVYELIIEISSV | 181 | Q16401 | |
| DLVYSLSLERISDGY | 76 | O15041 | |
| AYVRDLRSIVEDYLG | 116 | Q9H7P9 | |
| LSLYDGSRLLREDRY | 536 | A3KMH1 | |
| SYLERRLFSRLEDIY | 66 | A4D1P6 | |
| YIRAAEKLRQEIYSS | 681 | Q9UP52 | |
| YELVYTARTEGELLL | 386 | O75382 |